Literature DB >> 16240360

Toxic brainstem encephalopathy after artemisinin treatment for breast cancer.

Lori A Panossian, Nina I Garga, Daniel Pelletier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16240360     DOI： 10.1002/ana.20620

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  10 in total

1.  Antineoplastic activity of artemisinin in adrenocortical carcinoma.

Authors:  Luigi Lorini; Salvatore Grisanti; Roberta Ambrosini; Deborah Cosentini; Marta Laganà; Luigi Grazioli; Guido A M Tiberio; Sandra Sigala; Alfredo Berruti
Journal:  Endocrine       Date:  2019-09-06       Impact factor: 3.633

2.  Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether.

Authors:  Laurens Manning; Moses Laman; Madhu Page-Sharp; Sam Salman; Ilomo Hwaiwhanje; Namar Morep; Peter Siba; Ivo Mueller; Harin A Karunajeewa; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

3.  Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.

Authors:  A R Hasugian; H L E Purba; E Kenangalem; R M Wuwung; E P Ebsworth; R Maristela; P M P Penttinen; F Laihad; N M Anstey; E Tjitra; R N Price
Journal:  Clin Infect Dis       Date:  2007-03-05       Impact factor: 9.079

4.  Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.

Authors:  Ushma Mehta; David Durrheim; Aaron Mabuza; Lucille Blumberg; Elizabeth Allen; Karen I Barnes
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug.

Authors:  Maria P Crespo-Ortiz; Ming Q Wei
Journal:  J Biomed Biotechnol       Date:  2011-11-22

6.  Anticancer properties of distinct antimalarial drug classes.

Authors:  Rob Hooft van Huijsduijnen; R Kiplin Guy; Kelly Chibale; Richard K Haynes; Ingmar Peitz; Gerhard Kelter; Margaret A Phillips; Jonathan L Vennerstrom; Yongyuth Yuthavong; Timothy N C Wells
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.

Authors:  Mary A Bitta; Symon M Kariuki; Clifford Mwita; Samson Gwer; Leah Mwai; Charles R J C Newton
Journal:  Wellcome Open Res       Date:  2017-06-02

Review 8.  Safety profile of Coartem: the evidence base.

Authors:  Catherine Falade; Christine Manyando
Journal:  Malar J       Date:  2009-10-12       Impact factor: 2.979

9.  Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.

Authors:  George O Adjei; Jorgen A L Kurtzhals; Onike P Rodrigues; Michael Alifrangis; Lotte C G Hoegberg; Emmanuel D Kitcher; Ebenezer V Badoe; Roberta Lamptey; Bamenla Q Goka
Journal:  Malar J       Date:  2008-07-11       Impact factor: 2.979

10.  Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.

Authors:  Kanchan Kumari; Sunita Keshari; Debomita Sengupta; Surendra C Sabat; Sandip K Mishra
Journal:  BMC Cancer       Date:  2017-12-15       Impact factor: 4.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.